Concepedia

Christoph Gaul

CG

Statistics

Publications

31

Citations

2.1K

H-Index

25

Active since

2000

Affiliations

Novartis (Switzerland)(Current)

Novartis Institutes for BioMedical Research

Kettering University

Columbia University

ETH Zurich

Christoph Gaul is an author at Novartis (Switzerland) specializing in medicinal chemistry, pharmacology, and drug discovery.

ORCID

Publications per year

2000–2020

31

Publications

31

The Migrastatin Family:  Discovery of Potent Cell Migration Inhibitors by Chemical Synthesis

Christoph Gaul, Jón T. Njardarson, Dandan Shan et al. · Journal of the American Chemical Society · 2004 · 174 citations

, , +15

Discovery of Potent Cell Migration Inhibitors through Total Synthesis:  Lessons from Structure−Activity Studies of (+)-Migrastatin

Jón T. Njardarson, Christoph Gaul, Dandan Shan et al. · Journal of the American Chemical Society · 2004 · 165 citations

, , +13

Synthetic analogues of migrastatin that inhibit mammary tumor metastasis in mice

Dandan Shan, Lin Chen, Jón T. Njardarson et al. · Proceedings of the National Academy of Sciences · 2005 · 163 citations · Full text

, , +12

Genetic resistance to JAK2 enzymatic inhibitors is overcome by HSP90 inhibition

Oliver Weigert, Andrew A. Lane, Liat Bird et al. · The Journal of Experimental Medicine · 2012 · 162 citations · Full text

, , +14

CHZ868, a Type II JAK2 Inhibitor, Reverses Type I JAK Inhibitor Persistence and Demonstrates Efficacy in Myeloproliferative Neoplasms

Sara C. Meyer, Matthew D. Keller, Sophia Chiu et al. · Cancer Cell · 2015 · 155 citations

, , +13

1–5 of 31